https://www.avient.com/sites/default/files/2023-07/Versollan OM- Len Compartment -Application Snapshot.pdf
AVIENT SOLUTION
MEDICAL DEVICE
MANUFACTURER
C O M P A R T M E N T C O V E R
• Improve grip with a matte rubber finish
• Comply with RoHS Directive
• Provide superior adhesion to PC/ABS
• Achieved excellent adhesion to PC/ABS at a
lower wall thickness of to 2mm
• Improved aesthetics and usability with the
rubber finish provided by our custom
formulation
• Provided quick responses to customer queries
and accelerated time to market
KEY REQUIREMENTS
GOOD ADHESION + COMPLIANCE
LEARN MORE
Versollan™ Thermoplastic Elastomers
Copyright © 2023, Avient Corporation.
https://www.avient.com/sites/default/files/2023-12/Versaflex OM TPEs for Sealing Ring of Blood Lancet.pdf
BLOOD LANCET
MANUFACTURER
S E A L I N G R I N G
• Compliance with strict regulations for medical materials
• Excellent sealing performance
• Good compression set
• Provided a recycled TPE solutions
compared to silicone without increasing
system cost
• Delivered a TPE that complied with ISO
10993-4 & -5 and USP Class VI
• Supported a change to an injection molded
material to ease production and enhance
assembly capabilities
Versaflex™ HC TPEs – OM1040-1 Grade
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-11/Versaflex HC -Syringe tip cap-Case study snapshot.pdf
PRE-FILLED
SYRINGE COMPANY
S Y R I N G E T I P C A P
• Excellent sealing performance
• No DEHP or natural rubber latex added during processing
• Can be sterilized by EtO
• Compliant with ISO 10993-4&5 and USP Class VI
• Formulated a solution that met rigorous
medical application requirements
• Leveraged global footprint to ensure supply
continuity
• Increased process efficiency by replacing
previous thermoset material with a TPE
Versaflex™ HC Thermoplastic Elastomers
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2022-11/Versaflex CL-Serum collection cartridge-Application Snapshot.pdf
AVIENT SOLUTION
MEDICAL COMPLIANCE + SEALING
LEARN MORE
Copyright © 2022, Avient Corporation.
https://www.avient.com/news/polyone-announces-record-fourth-quarter-and-full-year-2014-results
Achieved 21st consecutive quarter of strong double-digit adjusted EPS growth
I am very pleased to report outstanding fourth quarter results which extends our streak to 21 consecutive quarters of strong double-digit adjusted earnings per share growth," said Robert M.
Patterson added, "I am confident we will deliver another year of strong double-digit adjusted EPS growth in 2015, and I look forward to further expanding on our Platinum Vision for 2020 with investors in May."
https://www.avient.com/news/polyone-announces-record-second-quarter-2015-results
Delivers quarterly double-digit EPS expansion of 12% to a record $0.57; GAAP EPS increases to $0.74, up from $0.33 in the prior year second quarter
I am very pleased to report we delivered double-digit adjusted earnings expansion of 12% for the second quarter and our 23rd consecutive quarter of EPS growth,” said Robert M.
Patterson said, “I am pleased we achieved double- digit EPS growth, which remains our ongoing objective.
https://www.avient.com/news/polyone-announces-strong-fourth-quarter-and-full-year-2013-results
Adjusted earnings per share increased 44% to $0.26 over the prior year quarter,17th consecutive quarter of double-digit adjusted earnings per share growth
Due to our unwavering focus on executing our four pillar strategy, we have now delivered 17 quarters of consecutive double-digit adjusted earnings per share growth, with a compounded annual growth rate of 24%, a distinguished performance that all of our associates are justifiably proud of.”
Newlin said, “We finished 2013 very strong, building on our momentum throughout the year, and we are in an excellent position for another record year in 2014 with strong double-digit adjusted earnings per share growth.
https://www.avient.com/sites/default/files/2022-01/Carbon Fiber Composites Infographic.pdf
Automotive
chassis
components,
body panels
Medical
splints, braces,
orthopedic
fixators
Avient’s Glasforms™ and Gordon Composites™ carbon fiber composite materials consist of
thermoset continuous fiber polymer rods, bars, laminates and custom shapes used in a variety
of applications that require superior technical characteristics.
https://www.avient.com/sites/default/files/2023-01/45324-Certificate-13JAN2023.pdf
ISO 13485:2016
The Quality Management System is applicable to:
Certificate No: 45324
Certification Date: 24 February 2014
Effective Date: 13 January 2023
Expiration Date: 23 January 2026
Revision Date: 13 January 2023 Dominic Townsend, President
DESIGN, MANUFACTURE AND DISTRIBUTION OF THERMOPLASTIC ELASTOMER RESINS & PELLETS FOR THE
MEDICAL DEVICE INDUSTRY
This certificate may be found on the ABS QE Website (www.abs-qe.com).
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Buyer acknowledges that Seller has furnished to Buyer
Safety Data Sheets, which include warnings together with safety and
health information concerning the Product and/or the containers for
such Product.
Personal Information' means information
relating to any person, including but not limited to: (i) information
relating to the race, gender, sex, pregnancy, marital status, national,
ethnic or social origin, colour, sexual orientation, age, physical or
mental health, well-being, disability, religion, conscience, belief,
culture, language and birth of the person; (ii) information relating to
the education or the medical, financial, criminal or employment
history of the person; (iii) information relating to the financial affairs
of the person; (iv) credit card details and transactional data; (v) any
identifying number, symbol, e-mail address, physical address,
telephone number or other particular assignment to the person; (vi)
biometric information about a person; (v) personal opinions, views
and preferences of a person; (vii) correspondence sent by the person
that is implicitly or explicitly of a private or confidential nature or
further correspondence that would reveal the contents of the original
correspondence; (viii) the views or opinions of another individual
about the person; (ix) the name of the person if it appears with other
personal information relating to the person or if the disclosure of the
name itself would reveal information about the person; and (x) any
other information which may be treated or defined as "personal
information" in terms of any applicable laws, including Data
Protection Legislation.